Suffolk Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-78,003	Closed	-$6.85M	–	126
2017 Q1	$6.85M	Buy	+78,003	New	+$6.85M	0.92%	43
2016 Q4	–	Sell	-61,348	Closed	-$5.68M	–	137
2016 Q3	$5.68M	Buy	+61,348	New	+$5.68M	0.78%	51